They found that one third of the tumors contained PD1-expressing T cells that clonally expanded after anti-PD1 therapy, regardless of tumor subtype, while some gene sets were positively or negatively correlated with T cell expansion following anti-PD1 treatment [29]. Here, PDCD1 is linked to neoplasm.